Literature DB >> 17761783

The association of gastric leptin with oesophageal inflammation and metaplasia.

F Francois1, J Roper, A J Goodman, Z Pei, M Ghumman, M Mourad, A Z Olivares de Perez, G I Perez-Perez, C-H Tseng, M J Blaser.   

Abstract

BACKGROUND: Gastro-oesophageal reflux disease complications may reflect imbalances between protective and injurious factors. Through its effects on cell growth, leptin may influence oesophageal mucosal homeostasis. AIMS: To determine whether leptin receptors are present in the oesophagus, and whether serum or gastric leptin levels are associated with oesophageal inflammation and metaplasia.
METHODS: From patients referred for upper endoscopy, biopsies were obtained from the stomach and distal oesophagus, and serum samples were collected. Patients were classified as having normal, inflamed or Barrett's oesophagus. Quantitative immunohistochemistry was performed on representative sections, and leptin levels in plasma and gastric biopsy samples were determined by specific immunoassay.
RESULTS: Of 269 individuals enrolled, 105 were Helicobacter pylori-negative. Of the 88 patients with complete oesophageal biopsies, 44 were normal, 24 were inflamed and 20 were Barrett's oesophagus. Receptors for leptin were highly expressed on oesophageal epithelial cells, with similar density and staining pattern in all three conditions, and plasma and antral leptin levels did not differ significantly. Patients with Barrett's had significantly (p = 0.01) higher fundic leptin levels (median 202 (interquartile range 123-333) pg/mg) compared with normal (126 (78-221) pg/mg) or inflamed (114 (76-195) pg/mg) oesophagus. In multivariate analysis, for every twofold increase in fundic leptin, the odds of having Barrett's was 3.4 times (95% CI 1.5 to 7.6) higher compared with having a normal oesophagus.
CONCLUSIONS: Leptin receptor expression on oesophageal epithelial cells provides a pathway for leptin-mediated signal transduction. Variation in gastric leptin production could contribute to differential oesophageal healing and metaplasia progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761783     DOI: 10.1136/gut.2007.131672

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

Review 2.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

3.  Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction.

Authors:  Olivia M Thompson; Shirley A A Beresford; Elizabeth A Kirk; Mary P Bronner; Thomas L Vaughan
Journal:  Obesity (Silver Spring)       Date:  2010-01-28       Impact factor: 5.002

Review 4.  Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Anamay N Sharma; Mohammad Hassan Murad; Navtej S Buttar; Hashem B El-Serag; David A Katzka; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-22       Impact factor: 11.382

Review 5.  Microbiome and malignancy.

Authors:  Claudia S Plottel; Martin J Blaser
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

Review 6.  Association of Serum Levels of Adipokines and Insulin With Risk of Barrett's Esophagus: A Systematic Review and Meta-Analysis.

Authors:  Apoorva Krishna Chandar; Swapna Devanna; Chang Lu; Siddharth Singh; Katarina Greer; Amitabh Chak; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

7.  Distribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett's esophagus.

Authors:  Eric M Nelsen; Yujiro Kirihara; Naoki Takahashi; Qian Shi; Jason T Lewis; Vikneswaran Namasivayam; Navtej S Buttar; Kelly T Dunagan; Ganapathy A Prasad
Journal:  Clin Gastroenterol Hepatol       Date:  2012-03-17       Impact factor: 11.382

8.  Decreased NPC1L1 expression in the liver from Chinese female gallstone patients.

Authors:  Wei Cui; Zhao-Yan Jiang; Qu Cai; Ru-Yuan Zhang; Wei-Ze Wu; Jian-Cheng Wang; Jian Fei; Sheng-Dao Zhang; Tian-Quan Han
Journal:  Lipids Health Dis       Date:  2010-02-08       Impact factor: 3.876

9.  Exercise and the Prevention of Oesophageal Cancer (EPOC) study protocol: a randomized controlled trial of exercise versus stretching in males with Barrett's oesophagus.

Authors:  Brooke M Winzer; Jennifer D Paratz; Marina M Reeves; David C Whiteman
Journal:  BMC Cancer       Date:  2010-06-16       Impact factor: 4.430

Review 10.  Helicobacter pylori in health and disease.

Authors:  Timothy L Cover; Martin J Blaser
Journal:  Gastroenterology       Date:  2009-05-07       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.